Erenumab Prevents Episodic Migraine in Refractory Patients Erenumab Prevents Episodic Migraine in Refractory Patients

The new phase 3b LIBERTY trial shows erenumab was safe and effective in patients with episodic migraine refractory to at least two previous preventive treatments.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news